DBV Technologies | DBVT - Le Revenu D'Intérêts





Le Revenu D'Intérêts Changement Date
Acadia Pharmaceuticals USD 8.06M 277K 2026-03
Alnylam Pharmaceuticals USD 26.6M 32K 2026-03
Amarin USD 3.37M 3.37M 2024-12
BioCryst Pharmaceuticals USD -0.13 3.59M 2024-12
BioMarin Pharmaceutical USD 22.56M 3.35M 2026-03
DBV Technologies USD -0.32 0.02 2024-09
Galectin Therapeutics USD -2.71M 2.77M 2023-12
Incyte USD 38.12M 4.43M 2026-06
Insmed USD 765K 55K 2024-09
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
Sarepta Therapeutics USD 7M 1.74M 2026-03
Ultragenyx Pharmaceutical USD 6M 512K 2026-03
United Therapeutics USD 31.5M 10.3M 2026-06